- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.05. | Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma | 4 | CNW | ||
| 27.04. | Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences | 1 | CNW | ||
| 16.04. | Sona Nanotech Inc: Sona Nanotech appoints Smylie, Trites to advisory board | 1 | Stockwatch | ||
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 16.04. | Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board | 1 | CNW | ||
| 13.04. | Sona Nanotech Inc: Sona Nanotech upbeat about THT's effect on tumours | 2 | Stockwatch | ||
| 13.04. | Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies | 2 | CNW | ||
| 08.04. | Sona Nanotech Inc: Sona says THT shows strong combo cancer efficacy | 3 | Stockwatch | ||
| 07.04. | Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy In Peer-reviewed Preclinical Study | 1 | CNW | ||
| 17.03. | Sona Nanotech Inc: Sona Nanotech to hold investor webinar March 18 | 3 | Stockwatch | ||
| 16.03. | Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study | 1 | CNW | ||
| 20.10.25 | Sona Nanotech Inc.: Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study | 683 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 20, 2025) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce the completion of its first-in-human clinical... ► Artikel lesen | |
| 17.10.25 | Sona Nanotech Inc.: Sona Nanotech To Host Investor Webinar To Discuss Clinical Study | 1.183 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon... ► Artikel lesen | |
| 25.08.25 | Sona Nanotech Inc.: Sona Provides Update on First-In-Human Clinical Trial | 965 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - August 25, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 23.07.25 | Sona Nanotech Inc.: Sona Announces Canadian Melanoma Clinical 'Pilot' Study Ethics Approval | 879 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 07.07.25 | Sona Nanotech Inc.: First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy | 1.024 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 7, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 27.06.25 | Sona Nanotech Inc.: Sona Announces Ethics Committee Approval For Melanoma Clinical Trial | 790 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 16.06.25 | Sona Nanotech Inc.: Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy | 720 | Newsfile | First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 20,700 | -3,72 % | RBC stuft Formycon auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Formycon nach Quartalszahlen mit einem Kursziel von 51 Euro auf "Outperform" belassen. Der Spezialist für Biosimilars habe... ► Artikel lesen | |
| OBDUCAT | 0,091 | -9,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| SOLESENCE | 1,385 | -0,36 % | Solésence, Inc.: Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results | Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,300 | -25,00 % | SMOLTEK NANOTECH HOLDING AB: Smoltek has decided on a partially guaranteed rights issue of approximately SEK 60 million | ||
| RIBER | 16,480 | +0,24 % | Riber: Margen steigen, KI-Boom treibt - Hidden Champion vor nächsten Kursschub? | Hightech "Made in France" mit Rückenwind durch KI und Photoniks: Riber verbessert trotz leicht rückläufigem Umsatz deutlich seine Profitabilität und könnte vor einem neuen Wachstumszyklus stehen. Riber... ► Artikel lesen | |
| ONTO INNOVATION | 238,20 | -0,38 % | Onto Innovation Forecasts 30% Revenue Growth for 2026: Can It Deliver? | ||
| NVE | 95,00 | -2,06 % | Dividendenbekanntmachungen (18.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2A SPA IT0001233417 - 0,104 EUR AIR LIQUIDE SA FR0000120073 - 3,7 EUR ALCOA CORPORATION CDIS AU0000339426 0,1 USD 0,086 EUR ALLISON... ► Artikel lesen | |
| KOPIN | 5,340 | +1,91 % | KOPIN CORP - 8-K, Current Report | ||
| GAUZY | 0,672 | -0,22 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F | TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on May 19, 2026... ► Artikel lesen | |
| VEECO INSTRUMENTS | 50,54 | -3,66 % | SVP At Veeco Instruments Sells $2.20M Of Stock | ||
| GOMSPACE | 1,767 | -1,23 % | GomSpace Group AB: Annual general meeting held in GomSpace Group AB (publ) | Today, the annual general meeting of 2026 has been held in GomSpace Group AB (publ) (the "Company" or "GomSpace"). Below follows a summary of the decisions taken by the annual general meeting (all... ► Artikel lesen | |
| DOTZ NANO | 0,026 | +11,49 % | Dotz Nano Secures Extended Maturity for Convertible Securities with Mercer Street Capital | ||
| CANATU | 10,200 | -0,39 % | Canatu Oyj: Inside information: Canatu announces a leadership transition - Dr. Maximilian Slawinski appointed as CEO and successor to Juha Kokkonen | Canatu Plc Inside information 11 May 2026 at 09:00 a.m. EEST
Inside information: Canatu announces a leadership transition - Dr. Maximilian Slawinski appointed as CEO and successor to Juha Kokkonen
Canatu's... ► Artikel lesen | |
| ZENTEK | 0,500 | +4,17 % | Zentek Ltd.: Zentek Announces Closing of Fully Subscribed Brokered LIFE Offering for Gross Proceeds of C$18 Million | Guelph, Ontario--(Newsfile Corp. - May 27, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce the closing of its previously announced "best efforts"... ► Artikel lesen | |
| ACACIA RESEARCH | 3,980 | +2,58 % | Acacia Research Q1 2026 slides show mixed results, strong liquidity |
Das Unternehmen SONA NANOTECH INC kann der Branche Nanotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONA NANOTECH INC finden Sie auf Wallstreet Online.